Lv3
340 积分 2022-03-02 加入
IL-33/ST2 axis in autoimmune disease
27天前
已完结
T cell dysfunction and therapeutic intervention in cancer
27天前
已完结
Beyond BRCA: Diagnosis and management of homologous recombination repair deficient pancreatic cancer
1个月前
已关闭
Molecular heterogeneity and co-altered genes in MET-amplified ALK-positive lung cancer: Implications for MET targeted therapy
3个月前
已完结
Analysis of rare fusions in NSCLC: Genomic architecture and clinical implications
3个月前
已完结
Clinical treatment patterns, molecular characteristics and survival outcomes of ROS1-rearranged non-small cell lung cancer: A large multicenter retrospective study
3个月前
已完结
Genomic and Immune Landscape Comparison of MET Exon 14 Skipping and MET-Amplified Non-Small Cell Lung Cancer
3个月前
已完结
MET Fusions in NSCLC: Clinicopathologic Features and Response to MET Inhibition
5个月前
已完结
Oncogene-driven non-small cell lung cancers in patients with a history of smoking lack smoking-induced mutations
5个月前
已完结
Evaluation of molecular residual disease in operable non-small cell lung cancer with gene fusions, MET exon skipping or de novo MET amplification
5个月前
已完结
皖公网安备34019202002308
